Press Release

🚀 Exciting News from LiveDrop! 🚀 We are thrilled to announce that LiveDrop has officially partnered with MicroOmix, a Strasbourg-based pioneer in high-throughput cell screening. Together, we are set to help antibody discovery with a solution that promises to significantly reduce screening times and accelerate the development of treatments for cancers, neurodegenerative, and autoimmune diseases. 💡🔬 This strategic collaboration combines the disruptive technologies of both companies, merging LiveDrop's expertise in microfluidic instruments and MicroOmix's patented chemistry to drive faster, more targeted antibody discovery—unlocking the full potential of antibody-based therapies. Learn more about this game-changing partnership and how we are transforming the future of biomedical innovation.